+ UDIBI admin_udibi3, 29 de August de 202329 de August de 2023, 2023, Uncategorized, 0 Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. SHOW MORE
+ UDIBI admin_udibi3, 29 de August de 202329 de August de 2023, 2023, Uncategorized, 0 An international comparative analysis and roadmap to sustainable biosimilar markets. SHOW MORE